The investigations encompass non-invasive methodology, involving conventional cognitive assessment and novel strategies to objectify ECG, HRV and fecal corticosterone. Results are shown in Fig 2 and Fig 3. For simplicity of understanding, the nomenclature of three groups is given below:
Immediate effects analysis
Group I: Control.
Group II: NCID1 (Nicotine + Caffeine Immediate Dose I).
Group III: NCID2 (Nicotine + Caffeine Immediate Dose II).
Third day effects analysis
Group I: Control.
Group II: NCTD1 (Nicotine + Caffeine Third day Dose I).
Group III: NCTD2 (Nicotine + Caffeine Third day Dose II).
Immediate effects analysis
The behavior testing and ECG recording were done two hours after injection whereas fecal boil for corticosterone assessment was collected six hours after injection (Fig 2).
Cognition results
In the EPM, the open arm entries percentage (Fig 2A) significantly increased. One way ANOVA showed significant differences between the dose groups and control [F (2,36) = 7.009, p=0.0035)], control 52.80% open arm entry, in NCID1 71.0, NCID2 73.10. The Tukey’s post-hoc test difference in mean is significant for control and NCID1 and Control and NCID2 (p < 0.05) but not for NCID1 and NCID2 (p = 0.98). One-way ANOVA test for percentage time in open arm (Fig 2B) showed non-significant difference between the groups with F (2,36) and p > 0.05, in Tukey’s post-hoc test non-significant differences between all groups observed at 0.05 level .Y maze spatial alternation memory (Fig 2C) One way ANOVA revealed significant effects of combined doses of nicotine and caffeine immediately after injection p<0.0001 with F (2,36) being 39.21. In Tukey’s post hoc test, significant differences were observed between means of control and both the dose groups but non-significant differences among means of the two dose groups.
ECG and HRV
One way ANOVA for heart rate (=BPM) on immediate analysis (Fig 2D) significant increase in heart beats in both dose groups with differences among groups F (2,36) = 69.12 and p<0.0001. In Tukey’s post hoc test there is a significant difference between control and both the doses but non-significant difference between the doses at 0.05 level. One-way ANOVA results for QTc (ms) intervals (Fig 2E) reveals QTc prolongation in two dose groups and there exists significant difference among all the groups with F (2,36) being 46.34, p<0.0001. The Tukey’s post hoc test denoted significant differences between means of Control and NCID1, NCID2 but non-significant differences between NCID1 and NCID2 at 0.05 levels. The Poincare plot HRV, SD1 (Fig 2F) F (2,36) = 4.7, p<0.0177 and SD2 (Fig 2G) (F (2,36) = 0.9262, p=0.4083) decreased for both the doses immediately after injection. but one-way ANOVA divulges its insignificant level. The SD1/SD2 (Fig 2H) decreased insignificantly F (2,36) = 1.861, p=0.1749.
Fecal corticosterone
Fecal corticosterone assessment reveals a non-significant increase in corticosterone concentration (Fig 2I) in both the dose groups immediately after administration.
Third day effects analysis
Considered nicotine and caffeine doses are clinically high, the third day or 48 hours. Post-injection assessment of cognition, ECG, HRV and fecal corticosterone provide better idea about how long their effects can last (Fig 3).
Cognition results
After 48 hours of dose overall percentage open arm entries in EPM (Fig 3A) decreased significantly for both the dose vis-à-vis control in one-way ANOVA results F (2,36) = 20.55 and p<0.0001. In Tukey’s post-hoc, a significant difference between means of all three comparable groups was observed. The one-way ANOVA for time spent in open arm (Fig 3B) showed significant decrease in both the dose groups with F (2,36) =20.02, p<0.0001. The Tukey’s post hoc depicted a significant difference in the mean of Control and NCTD1 and NCTD2. Y maze spatial alternation memory (Fig 3C) one way ANOVA test results on third day showed non-insignificant increase in both the dose group F (2,36) = 1.0974, p=0. 3479.
ECG, HRV
One way ANOVA for heart rate (Fig 3D) on third day significantly increased in both the dose group with F (2,36) = 107.4 and p<0.0001. The Tukey’s post hoc depicted significant difference between control and both the doses but non-significant difference between the two doses at 0.05 level. The one-way ANOVA for QTc (ms) intervals (Fig 3E) on third day reveals QTc prolongation in two dose groups and there exists significant difference among all the groups with F (2,36) being 51.64, p<0.0001. The Tukey’s post hoc test denoted that there exist significant differences between means of Control and NCTD1, NCTD2 but non-significant differences between NCTD1 and NCTD2 at 0.05 levels. In SD1 (Fig 3F) the One-way ANOVA revealed non-significant effects of combined doses of nicotine and caffeine on third day of injection F (2,36) = 1.804, p=0.1821. The Tukey’s post hoc test revealed non-significant differences between means of different groups at 0.05 level. The SD2 (Fig 3G) significantly increased in the dose group in one way ANOVA F (2,36) = 6.917, p=0.0034. The Sympathovagal balance calculated via SD1/SD2 (Fig 3H) showed a significant decrease in both the dose group with one way ANOVA F (2,36) =7.182, p=0.0028.
Fecal corticosterone
Regarding corticosterone estimation (Fig 3I) the one-way ANOVA F (2,36) = 4.203, p=0.0237 shows significant increase in both the dose group, in Tukey’s post-hoc the difference among two dose groups remains insignificant.
The study fulfills twin objectives with conviction. Firstly, demonstrating anxiogenic attributes of combined acute doses of nicotine and caffeine and secondly utility of novel non-invasive methodology.
Cognitive response
Cognitive enhancement observed in the EPM immediately after co-administration of caffeine and nicotine agrees with
Azza et al., (2016) via dopaminergic transmission (
Pistillo, 2015) in limbic system. Caffeine raises dopamine and lowers serotonin (
Myers, 2020), nicotine blocks dopamine uptake and increases synaptic dopamine release (
Pistillo, 2015) inducing arousal. Again, as per
Mourad et al. (2021) the co-administration of caffeine and nicotine decreases glutamate and increases GABA (Gamma-aminobutyric Acid) in Rat brain inducing anxiolytic behavior (
Myers, 2020).
Marked decrease in spatial alternation memory immediately after dose administrations contradictory to existing evidence (
Han et al., 2014;
Keloglan et al., 2022), warranting detailed investigations.
On the third day of drug co-administration anxiety induced can be attributed to oxidative stress due to nicotine and sleep deprivation due to both caffeine and nicotine as per (
Amiri and Behnezhad, 2020 and
Chaudhary et al., 2019).
A non-significant rise in spatial working memory is puzzling observation. Can be ascribed to altered HPA (Hypothalamus-pituitary adrenal) axis causing increased adrenaline and corticosterone release
(Xie et al., 2018) enhancing spatial working memory (
Mc Reynolds et al., 2014).
ECG-Heart rate and QTc
High heart rate and prolonged QTc were seen in immediate condition also on third day, can be due to caffeine increasing calcium release from intracellular sources and stimulating release of adrenaline thereby increasing contractability of myocardium (Robinson
et al., 2013). Nicotine increases heart rate through autonomic modulation
(Benowitz et al., 2016) and direct inhibition of potassium channels of ventricular myocytes by nicotine
(Ip et al., 2020) causes QTc prolongation.
HRV
Heart rate variability measures beat-to-beat heart rate variations are proxy of autonomic functioning and stress
(Arakaki et al., 2023). The non-linear parameters are better suited for diagnosing cognition and mood (
Young and Benton, 2015). The SD1, SD2, SD1/SD2 HRV markers pertinently decreased on third day under the influence of nicotine caffeine combined dose highlighting enhanced sympathetic dominance. Which can be through an efferent signal coming from the brain stem under the influence of nicotine and caffeine or because of disturbed HPA axis or direct action of these psychoactive substances on adrenal gland.
On the third day, sympathetic dominance enhanced, ascribed to elevated adrenaline that acts on brain stem circuits and promotes anxiety (
Montoya et al., 2016).
Corticosterone
Blue tetrazolium assay showed elevated fecal corticosterone can be due to stimulatory modulation of nicotine and caffeine on hypothalamus-pituitary-adrenal (HPA) axis
(Lutfy et al., 2006). Corticosterone has a role in enhancing anxiety
(Peng et al., 2021) and impairing cardiac functions (
Oakley and Cidlowski, 2015)
.
Overall observations of this research further strengthen the idea of bidirectional dynamic relationship between psychological and physiological health (
Forte and Casagrande, 2025).
The refinement policy of this research
This research used non-invasive methodology to assess anxiety convincingly contributed to refinement procedures in animal research. The refinement of animal experimentation methodology reduces distress and suffering and provides humane, accurate and reliable outcomes that can be easily extrapolated for human studies
(Rinwa et al., 2024).